TG Therapeutics, Inc. (TGTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $8.90B, a trailing price-to-earnings ratio of 109.6 and a free-cash-flow yield of -0.3%. Over the most recent reported fiscal year, revenue grew 87.3%.